beginner7 min readエビデンス確認日： 2026年9月28日

What Are Nootropics? A Complete Beginner Guide

Everything you need to know before taking your first nootropic supplement — what they are, how they differ from stimulants, and what the evidence actually says.

The definition

The term "nootropic" was coined in 1972 by Romanian psychologist Corneliu Giurgea, who defined nootropics as substances that enhance learning and memory, protect the brain from injury, increase the efficacy of cortical and subcortical control mechanisms, and have no sedative or stimulant effects. Modern usage is broader: nootropics now refers to any supplement, drug, or compound taken with the goal of enhancing cognitive function — including memory, focus, creativity, motivation, or mental clarity.

Nootropics vs. stimulants

Stimulants (caffeine, modafinil, Adderall) produce short-term performance boosts primarily by increasing catecholamine release — but often at the cost of rebound fatigue, dependency, and disrupted sleep. True nootropics, by Giurgea's original criteria, should enhance cognition without producing significant stimulant effects or withdrawal. Most modern supplements fall in between: they combine stimulant and nootropic ingredients to deliver both acute and long-term benefits. Understanding this distinction helps you set realistic expectations.

Types of nootropics

Nootropic supplements fall into several categories: (1) Adaptogens (Ashwagandha, Rhodiola Rosea) — reduce stress hormones and support cognitive resilience under pressure. (2) Cholinergics (Citicoline, Alpha-GPC, Huperzine A) — support acetylcholine synthesis or inhibit its breakdown; important for memory and learning. (3) Racetams (Piracetam, Aniracetam) — synthetic compounds that show no measurable binding affinity for glutamate receptors; the leading hypothesis is indirect modulation of ion flux through AMPA-type glutamate-receptor channels, and no mechanism of action is fully established. Their legal status varies: prescription-only in the UK and Australia, while in the US the FDA treats piracetam as an unapproved drug that cannot lawfully be sold as a dietary supplement. (4) Mushrooms (Lion's Mane, Reishi) — Lion's Mane contains hericenones and erinacines shown to promote neurotrophic factor expression, including NGF (Nerve Growth Factor); Reishi's evidence base is mainly immune-modulating and antioxidant, not NGF stimulation. (5) Amino acids (L-Theanine, L-Tyrosine) — precursors to neurotransmitters; the most studied and safest category.

What the science actually shows

The honest answer: the evidence varies enormously by ingredient. L-Theanine paired with caffeine has robust acute RCT evidence for calm focus. Bacopa Monnieri's evidence for memory is mixed but net-positive and dose-dependent: network meta-analyses of roughly 25–29 RCTs support memory benefits, particularly at higher doses (600mg/day or more) over multi-week courses, but a 2025 12-week RCT in 101 healthy adults found no significant difference in verbal learning, attention, or working memory. Lion's Mane has promising but limited human trial data for long-term neuroprotection. Many products on the market combine clinically-backed ingredients at sub-clinical doses with well-marketed but under-studied compounds. The single most important question to ask about any nootropic is: what dose of each ingredient is in this formula, and does it match what was used in clinical trials?

Are nootropics safe?

Most mainstream nootropic supplements use food-grade or well-studied ingredients at doses considered safe for healthy adults. However, "natural" does not mean risk-free. Some ingredients interact with medications, and two interactions are serious enough to treat as contraindications: Huperzine A with cholinesterase-inhibitor medications (including Alzheimer's drugs such as Donepezil), and Rhodiola with MAO-inhibitor (MAOI) antidepressants. If you take either type of medication, do not add these ingredients without your prescriber's approval. A few ingredients carry regulatory restrictions in certain countries. Always consult a qualified healthcare professional before starting any supplement, especially if you take prescription medications or have a pre-existing health condition.

Nootropics in Japan

Nootropics sold or imported into Japan fall under two very different legal tracks. A product the maker has notified to the Consumer Affairs Agency (CAA) as a Food with Function Claims (FFC), or one approved as a Food for Specified Health Use (FOSHU, widely called Tokuho), may state a specific function on its label; a third category, Foods with Nutrient Function Claims (栄養機能食品), covers standardised claims for specified nutrients only. A product with neither a notification nor an approval behind it — which is the position of an imported stack brought in through personal import — has no route to state a memory, focus or brain-function claim on its label. The CAA does not independently test an FFC product's evidence; it reviews the notification, and the notifying business carries responsibility for the science behind the claim.

A notification system, not a government approval

The CAA explains the Foods with Function Claims system in its own words: a business can display a functionality claim if it notifies the Commissioner of the Consumer Affairs Agency of the necessary matters, such as scientific evidence on the safety and function of the food, before sale (our translation), based on rules the government sets. Crucially, the same CAA page states that unlike FOSHU, the government does not conduct an examination (our translation), so the notifying business must, at its own responsibility, provide appropriate labeling grounded in scientific evidence. A notification is a filing, not a stamp of government-verified efficacy.

Why an unnotified imported stack cannot make claims

Japan's health-food guidance from the Ministry of Health, Labour and Welfare (MHLW) is direct about products outside this notified or approved system: even without an added pharmaceutical ingredient, a food carrying wording like "effective against ○○" or "cures △△" is described as a drug-like label or expression, and MHLW states this also violates the Pharmaceutical Affairs Act (our translation). A nootropic stack imported for personal use, with no CAA notification behind it, sits in this unclaimable category — it can be sold or used as a food, but the label cannot legally describe a cognitive effect.

Products in Japan

Consumer Affairs Agency (FFC)

Does "機能性表示食品" (Foods with Function Claims) on a Japanese label mean the government verified the product works?

No. The CAA's own description of the system says a business may display a function claim once it notifies the Commissioner of the Consumer Affairs Agency of its supporting evidence before sale (our translation), and explicitly notes that, unlike FOSHU/Tokuho, the government does not conduct an examination (our translation) The filing is reviewed for completeness, not independently tested by the CAA.

Can an imported nootropic supplement legally say it improves memory in Japan?

Only if it has gone through CAA notification (FFC) or FOSHU approval. MHLW's health-food guidance states that a food using "drug-like" wording such as claiming a product is effective against or cures a condition violates the Pharmaceutical Affairs Act (our translation) even when no pharmaceutical ingredient is present — a rule that applies squarely to unnotified imported stacks.

What's the difference between FOSHU (Tokuho) and Foods with Function Claims?

Per the CAA, FOSHU involves government examination of the individual product, while under the FFC system the government does not conduct an examination (our translation) — the business notifies the CAA of its own evidence and takes responsibility for the label's accuracy. Both are legal categories distinct from an ordinary, unnotified imported supplement.

Prefecture guides

Sources: Consumer Affairs Agency (CAA) — 機能性表示食品について (About Foods with Function Claims) · MHLW / National Institute of Health and Nutrition — 健康食品の正しい利用法 (Correct Use of Health Foods) · CAA — food labelling categories (栄養機能食品 / 機能性表示食品 / 特定保健用食品)

Regulatory note

本ページは教育目的の編集コンテンツであり、医学的助言を構成するものではありません。日本国内で販売される機能性表示食品（FFC）および特定保健用食品（FOSHU）は、消費者庁への届出または許可を必要とします。届出のない輸入品については、日本の薬機法（旧薬事法）の下で疾病治療を示唆する表現は規制されます。サプリメントを開始する前に、必ず資格のある医療専門家にご相談ください。This page is editorial and not medical advice. Foods with Function Claims (FFC) and Foods for Specified Health Uses (FOSHU) sold in Japan require notification or approval from the Consumer Affairs Agency. Imported products without notification cannot make disease-treatment claims under the Pharmaceuticals and Medical Devices (PMD) Act. Note: In July 2026, the Consumer Affairs Agency (CAA) opened a public comment period (Notice No. 235080088, closes 30 July 2026) on proposed revisions to permitted claim wording for FFC-notified ingredients including DHA, phosphatidylserine, and NMN; compliant claim language may require updating once the final Cabinet Office Order is published. Consult a qualified healthcare professional before starting any supplement.

出典 (6)展開

← Back to Guides